Tomáš Milota

发表

Principles and Challenges in anti-COVID-19 Vaccine Development

J. Bartůňková, Z. Strizova, J. Smetanova, 2021, International Archives of Allergy and Immunology.

Negativity for Specific Autoantibodies in Patients with Type 1 Diabetes That Developed on a Background of Common Variable Immunodeficiency

P. Kralickova, A. Šedivá, Z. Šumník, 2016, International Archives of Allergy and Immunology.

Managing Granulomatous–Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey

A. Gennery, B. Fevang, A. Prasse, 2020, Frontiers in Immunology.

Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet+ B cells

S. Pittaluga, V. Kanderova, L. Notarangelo, 2022, Nature Immunology.

Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs

A. Šedivá, H. Zelená, J. Smetanova, 2022, Frontiers in Immunology.

Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis

A. Šedivá, Tomáš Milota, Z. Parackova, 2022, Frontiers in Immunology.

Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A worldwide study

C. Pignata, W. Al-Herz, D. El-Ghoneimy, 2022, The World Allergy Organization journal.

Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation

T. Kalina, V. Kanderova, E. Froňková, 2018, Journal of Clinical Immunology.

Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study

J. Drabek, S. Coufal, M. Trojánek, 2022, PloS one.

Accelerated Maturation, Exhaustion, and Senescence of T cells in 22q11.2 Deletion Syndrome

A. Šedivá, J. Smetanova, Tomáš Milota, 2021, Journal of Clinical Immunology.

SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients

H. Zelená, J. Smetanova, Tomáš Milota, 2022, Frontiers in Immunology.

Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence

V. Kanderova, A. Šedivá, Tomáš Milota, 2021, Frontiers in Pediatrics.

Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab

A. Šedivá, Z. Strizova, J. Smetanova, 2021, The Lancet Rheumatology.

Gastrointestinal Involvement in Primary Antibody Deficiencies

J. Smetanova, Tomáš Milota, I. Klojdová, 2023, Gastrointestinal Disorders.

Mutual alteration of NOD2-associated Blau syndrome and IFNγR1 deficiency

J. Casanova, E. Froňková, A. Šedivá, 2019, Journal of Clinical Immunology.

Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?

A. Šedivá, I. Stříž, Z. Strizova, 2021, Frontiers in Pharmacology.

The Clinical and Genetic Spectrum of 82 Patients With RAG Deficiency Including a c.256_257delAA Founder Variant in Slavic Countries

M. van der Burg, L. Notarangelo, J. Walter, 2020, Frontiers in Immunology.

Hyper‐IgE in the allergy clinic––when is it primary immunodeficiency?

Mark J. Ponsford, A. Šedivá, J. Litzman, 2018, Allergy.

IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives

A. Šedivá, I. Stříž, Z. Strizova, 2021, Frontiers in Immunology.

Dissection of the Pre-Germinal Center B-Cell Maturation Pathway in Common Variable Immunodeficiency Based on Standardized Flow Cytometric EuroFlow Tools

M. van der Burg, T. Kalina, M. Pérez‐Andrés, 2021, Frontiers in Immunology.

Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?

J. Smetanova, Tomáš Milota, I. Klojdová, 2023, Pharmaceuticals.

Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies

J. Bartůňková, J. Smetanova, Tomáš Milota, 2023, Pathogens.

CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID

T. Kalina, V. Kanderova, D. Jílek, 2019, Front. Immunol..

Initial presenting manifestations in 16,486 patients with Inborn Errors of Immunity include infections and non-infectious manifestations.

Nurit Assia Batzir, K. Schwarz, D. Foell, 2021, The Journal of allergy and clinical immunology.

An immunologist's perspective on anti-COVID-19 vaccines

A. Šedivá, Z. Strizova, J. Smetanova, 2021, Current opinion in allergy and clinical immunology.

Czech Hizentra Noninterventional Study With Rapid Push: Efficacy, Safety, Tolerability, and Convenience of Therapy With 20% Subcutaneous Immunoglobulin.

D. Jílek, P. Kralickova, A. Šedivá, 2019, Clinical therapeutics.

Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study

D. Jílek, P. Kralickova, A. Šedivá, 2022, Frontiers in Immunology.

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study

Bodo Grimbacher, James Curtis, Siobhan O. Burns, 2017, The Journal of allergy and clinical immunology.

Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA

K. Pavelka, Tomáš Milota, R. Horváth, 2022, Therapeutic advances in musculoskeletal disease.

Medical algorithm: Diagnosis and management of antibody immunodeficiencies

A. Šedivá, J. Litzman, S. Burns, 2021, Allergy.

Novel XIAP mutation causing enhanced spontaneous apoptosis and disturbed NOD2 signalling in a patient with atypical adult-onset Crohn’s disease

V. Kanderova, A. Šedivá, T. Freiberger, 2020, Cell Death & Disease.